An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)
This study has been completed.
Study NCT00000649
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received on November 2, 1999.
Last Updated on July 29, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
